Follow
Yi Li
Title
Cited by
Cited by
Year
Current and emerging options for taxol production
Y Li, G Zhang, BA Pfeifer
Biotechnology of isoprenoids, 405-425, 2015
592015
Directed vaccination against pneumococcal disease
Y Li, A Hill, M Beitelshees, S Shao, JF Lovell, BA Davidson, PR Knight III, ...
Proceedings of the National Academy of Sciences 113 (25), 6898-6903, 2016
482016
Heterologous production of plant-derived isoprenoid products in microbes and the application of metabolic engineering and synthetic biology
Y Li, BA Pfeifer
Current opinion in plant biology 19, 8-13, 2014
452014
Tailoring pathway modularity in the biosynthesis of erythromycin analogs heterologously engineered in E. coli
G Zhang, Y Li, L Fang, BA Pfeifer
Science Advances 1 (4), e1500077, 2015
442015
Comprehensive vaccine design for commensal disease progression
CH Jones, G Zhang, R Nayerhoda, M Beitelshees, A Hill, P Rostami, Y Li, ...
Science Advances 3 (10), e1701797, 2017
322017
In situ pneumococcal vaccine production and delivery through a hybrid biological-biomaterial vector
Y Li, M Beitelshees, L Fang, A Hill, MK Ahmadi, M Chen, BA Davidson, ...
Science Advances 2 (7), e1600264, 2016
272016
Deoxysugar pathway interchange for erythromycin analogues heterologously produced through Escherichia coli
M Jiang, H Zhang, SH Park, Y Li, BA Pfeifer
Metabolic Engineering 20, 92-100, 2013
252013
Enhancing vaccine effectiveness with delivery technology
M Beitelshees, Y Li, BA Pfeifer
Current opinion in biotechnology 42, 24-29, 2016
122016
Bimodal targeting using sulfonated, mannosylated PEI for combined gene delivery and photodynamic therapy
U Chitgupi, Y Li, M Chen, S Shao, M Beitelshees, MJ Tan, ...
Photochemistry and photobiology 93 (2), 600-608, 2017
72017
Antigen delivery format variation and formulation stability through use of a hybrid vector
M Beitelshees, A Hill, Y Li, M Chen, MK Ahmadi, RJ Smith Jr, ...
Vaccine: X 1, 100012, 2019
32019
The system can't perform the operation now. Try again later.
Articles 1–10